Return to search

Investigating the Interaction Mechanism and Effect of ATP on Alpha-Synuclein Aggregation by NMR Spectroscopy

Recent studies suggest that Adenosine Triphosphate (ATP) can either enhance or inhibit the aggregation of amyloid proteins, depending on the interaction mechanism as well as specific protein properties. The connection between ATP and protein solubility is particularly important in Parkinson’s Disease (PD), where the aggregation of alpha-synuclein (αS) is closely linked to pathology. Since the greatest risk factor for PD is aging, and ATP levels decline dramatically with age and are greatly reduced in the brains of patients with early PD, it is possible that the modulating effect of ATP on protein solubility is a factor in PD onset. However, the driving mechanism behind the interaction of ATP and αS is currently unclear, as is the effect of physiologically-relevant ATP concentrations on early- and late-stage αS aggregation. Here, we determine using NMR spectroscopy that the triphosphate moeity of ATP drives its electrostatic interaction primarily with the N-terminal pseudo-apolipoprotein repeats of αS monomers. These interactions are modulated by magnesium and disrupt long-range N- to C-terminal contacts in αS monomers, causing a concentration-dependent enhancement of initial αS aggregation. We also show by Thioflavin T fluorescence as well as electron microscopy that ATP inhibits late-stage αS β-sheet fibril formation in a phosphate-dependent manner. Our NMR data reveals that ATP inhibits αS monomer-fibril interactions, suggesting that ATP attenuates αS secondary nucleation. Lastly, we show that the effects of ATP are different in the presence of PD-related αS mutations E46K and A53T. Overall, our study contributes a thorough characterization of the biologically- and pathologically-relevant interactions between ATP and αS, while also proposing a role for ATP in the age-related development of PD pathology. / Thesis / Master of Science (MSc) / Alpha-synuclein (αS) is a protein whose abnormal aggregation is characteristic of Parkinson’s Disease (PD). Adenosine Triphosphate (ATP) is a molecule that has recently been shown to reduce the aggregation of select disease-causing proteins. Therefore, the aim of this study is to characterize the interaction mechanism between ATP and αS, to explore how this interaction influences αS structural dynamics and to determine the effect of ATP on early- and late-stage αS aggregation. Another overall aim of this study is to characterize how the ATP-αS interaction is influenced by PD-related mutations in αS. To accomplish these aims, we will rely primarily on NMR spectroscopy as well as fluorescence and microscopy techniques. Our goal is to determine the role of ATP in αS aggregation as well as potentially connect the age-related decrease in ATP levels with PD, an age-related disease.

Identiferoai:union.ndltd.org:mcmaster.ca/oai:macsphere.mcmaster.ca:11375/27909
Date January 2022
CreatorsKamski-Hennekam, Evelyn
ContributorsMelacini, Giuseppe, Chemical Biology
Source SetsMcMaster University
LanguageEnglish
Detected LanguageEnglish
TypeThesis

Page generated in 0.0016 seconds